| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA380121
Max Phase: Preclinical
Molecular Formula: C23H28O5
Molecular Weight: 384.47
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCCOc1ccc(C(=O)c2ccc(OCC(C)C)cc2)cc1CCC(=O)O
Standard InChI: InChI=1S/C23H28O5/c1-4-13-27-21-11-7-19(14-18(21)8-12-22(24)25)23(26)17-5-9-20(10-6-17)28-15-16(2)3/h5-7,9-11,14,16H,4,8,12-13,15H2,1-3H3,(H,24,25)
Standard InChI Key: BJPJPSSSIHSEJF-UHFFFAOYSA-N
Associated Targets(Human)
Transcription factor AP1 124 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 384.47 | Molecular Weight (Monoisotopic): 384.1937 | AlogP: 4.76 | #Rotatable Bonds: 11 |
| Polar Surface Area: 72.83 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.83 | CX Basic pKa: | CX LogP: 5.32 | CX LogD: 2.07 |
| Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.57 | Np Likeness Score: -0.32 |
References
| 1. Tsuchida K, Chaki H, Takakura T, Kotsubo H, Tanaka T, Aikawa Y, Shiozawa S, Hirono S.. (2006) Discovery of nonpeptidic small-molecule AP-1 inhibitors: lead hopping based on a three-dimensional pharmacophore model., 49 (1): [PMID:16392794] [10.1021/jm050550d] |
Source
Source(1):